As of April 2025 Genmab has a market cap of HK$99.72 Billion. This makes Genmab the world's 1369th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | HK$99.72 B | -4.32% |
2024 | HK$104.22 B | -35.84% |
2023 | HK$162.43 B | -25.63% |
2022 | HK$218.41 B | 6.97% |
2021 | HK$204.18 B | -1.29% |
2020 | HK$206.85 B | 84.23% |
2019 | HK$112.28 B | 42.99% |
2018 | HK$78.52 B | -0.29% |
2017 | HK$78.75 B | 1.22% |
2016 | HK$77.80 B | 25.47% |
2015 | HK$62.01 B | 138.57% |
2014 | HK$25.99 B | 65.06% |
2013 | HK$15.74 B | 192.87% |
2012 | HK$5.37 B | 135.72% |
2011 | HK$2.28 B | -51.65% |
2010 | HK$4.71 B |
On Apr 24th, 2025 the market cap of Genmab was reported to be: